Sun Pharma, Lupin recall drugs in US on manufacturing woes

NEW DELHI: Leading drug makers Sun Pharma and Lupin are recalling products in the US market over manufacturing issues, as per the US Food and Drug Administration (FDA). Mumbai-based Sun Pharmaceutical Industries is recalling 96,192 bottles of Liothyronine Sodium Tablets in the US that are used to treat an underactive thyroid, according to the latest enforcement report issued by the American health regulator.

Princeton-based Sun Pharmaceutical Industries, a unit of the company, is recalling the affected lot that was produced at the drug maker's Dadra-based facility. The company is recalling the lot due to "failed impurities/degradation specifications", the FDA stated. The company commenced the voluntary nationwide Class II recall on December 4 this year.

The FDA stated that Mumbai-based Lupin is also recalling an unspecified number of penicillamine tablets in the US. The medication is used to treat rheumatoid arthritis and Wilson's disease. As per the FDA, the company is recalling the affected lot due to "failed dissolution specifications".